The DOI matches its Crossref record, with a small difference in title or year; 9 of the 9 references it cites were found in a registry or an index.
Antidepressant Discontinuation and Risk of Suicide Attempt: A Retrospective, Nested Case-Control Study
Abstract
OBJECTIVE: Prior efforts to assess the impact of antidepressant use on risk of suicide attempt focused on antidepressant initiation or duration of use. Gaps remain in understanding risks associated with antidepressant discontinuation in the context of the drug regimen. We assessed the effects of antidepressant discontinuation on the risk of suicide attempt. METHOD: We report a nested case-control study of suicide attempt with at least 12 months of prior observation. A retrospective cohort of 2.4 million patients with depression (ICD-9 codes 296.2, 296.3, 300.4, and 311), aged 5-89 years, was created using standard Healthcare Effectiveness Data and Information Set (HEDIS) criteria; from this cohort, cases (n = 10,456) and controls (n = 41,815) were selected for study. Data were from a large, national, longitudinal, integrated claims database of managed care enrollees in the United States from calendar years 1999 through 2006. RESULTS: Compared to controls, cases were more likely to have used antidepressants, to have had multiple antidepressants, and to have had prior depressive episodes and inpatient stays that involved depression. After adjusting for confounding due to depression severity, comorbidities, and other medications, antidepressant use showed a protective effect for suicide attempt (OR = 0.62, P < .001). Compared to prior therapy, antidepressant discontinuation had a significant risk for suicide attempt (OR = 1.61, P < .05). Antidepressant initiation had the highest risk for suicide attempt (OR = 3.42, P < .05), followed by titration (titration up, OR = 2.62; down, OR = 2.19; P < .05). CONCLUSIONS: Substantial confounding exists in examining the link between antidepressant use and suicide attempt, specifically regarding those factors associated with characteristics of depression. Antidepressant discontinuation showed a significant risk for suicide attempt, as did the period of an abbreviated trial, that is, stopping before a therapeutic regimen of 56 days had been reached. The highest risk was associated with initiation, a finding consistent with other studies, closely followed by periods of dosing changes and discontinuation. Patients should be closely monitored during these periods.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However,”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Valuck 2009
In the citing paper
“The conclusion that suicide was”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Valuck 2009
In the citing paper
“In one study, the syndrome lasted for at least twelve weeks in 25% of patients 18 , and in another for at least six weeks in 40% of people 20 .A third study reported that 86.7% responded that the syndrome had lasted at least two months, 58.6% at least one year, and 16.2% for more than three years 21 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [20]
In the citing paper
“Fluoxetine should take 35-75 days to reach steady state 49 , a fact that is likely responsible for observations that its withdrawal symptoms can arise weeks after cessation 9,20 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [20]
Citations
Cites
Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086 · cited 1×
“In their metaanalyses of antidepressant clinical trials, however, the FDA noted that there were no completed suicides and only infrequent suicide attempts reported in the trials.(4,5) Only when the endpoints of suicidal ideation and “possible” suicidal ideation were included did the meta-analyses yield significant eff…”
BackgroundSuicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054 · cited 1×
“In their metaanalyses of antidepressant clinical trials, however, the FDA noted that there were no completed suicides and only infrequent suicide attempts reported in the trials.(4,5) Only when the endpoints of suicidal ideation and “possible” suicidal ideation were included did the meta-analyses yield significant eff…”
BackgroundPosner, K., Oquendo, M. A., Gould, M., Stanley, B., & Davies, M. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1035 · Cited by 1,025 · cited 1×
“Suicidality is a term that encompasses a large range of behaviors and thoughts, including completed suicide, suicide attempt, planning or other preparatory action, and suicidal ideation.(1) Concern over a possible link between suicidality and antidepressant use has led the US Food and Drug Administration (FDA) to take…”
BackgroundSuicide Risk During Antidepressant Treatment
Simon, G. E., Savarino, J., Operskalski, B., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.41 · Cited by 424
Decline in Treatment of Pediatric Depression After FDA Advisory on Risk of Suicidality With SSRIs
Libby, A. M., Brent, D. A., Morrato, E. H., Orton, H. D., Allen, R., & Valuck, R. J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.884 · Cited by 281 · cited 1×
“Prescriber type for the antidepressant was indicated as primary care physician (internist, family medicine practitioner, obstetrician/gynecologist), psychiatrist, other mental health specialist (psychologist, social worker, psychiatric nurse), other non–mental health specialist, or other physician/unknown specialty ty…”
BackgroundSelf-citationValuck, R. J., Libby, A. M., Sills, M. R., Giese, A. A., & Allen, R. R. (2004) · CNS Drugs · doi:10.2165/00023210-200418150-00006 · Cited by 182 · cited 4×
“Consistent with Simon and colleagues,(7,19) our findings reveal the entire 55-day initiation period as the highest risk for suicide attempt, and consistent with our earlier pediatric work, longer duration reduced risk of suicide attempt.(8) The association between antidepressant use and the risk of suicidality is a cl…”
BackgroundMethodResultInfluentialSelf-citationSuicide Attempts Among Patients Starting Depression Treatment With Medications or Psychotherapy
Simon, G. E., & Savarino, J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1029 · Cited by 168 · cited 1×
“One cohort study showed an increase in suicide attempt risk in the month immediately prior to initiation of antidepressant therapy and in the first 4 to 8 weeks of therapy.(7) Another cohort study showed that suicide attempt risk decreased as duration of treatment increased.”
BackgroundIsotretinoin, pregnancies, abortions and birth defects: a population‐based perspective
Bérard, A., Azoulay, L., Koren, G., Blais, L., Perreault, S., & Oraichi, D. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02837.x · Cited by 117 · cited 1×
“Pregnancy was noted for any female patient in the observation period using ICD-9 codes and pregnancy-related procedure codes.(14) The following psychiatric disorders were included as indicator variables: bipolar disorder, schizophrenia, anxiety spectrum, substance use disorder, and other mental health problem.”
MethodNCQA Behavioral Health Measurement Efforts
Hudson, S. (2005) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2005.11.3.s9 · Cited by 16
Cited by
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
“Further, antidepressant discontinuation has been associated with an increased risk of suicide (Valuck et al., 2009).”
BackgroundNarouze, S., Benzon, H. T., Provenzano, D. A., Buvanendran, A., De Andres, J., Deer, T. R., Rauck, R., & Huntoon, M. A. (2015) · Regional Anesthesia and Pain Medicine · doi:10.1097/aap.0000000000000223 · Cited by 362
Tapering of SSRI treatment to mitigate withdrawal symptoms
Horowitz, M. A., & Taylor, D. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30032-x · Cited by 280
Narouze, S., Benzon, H. T., Provenzano, D., Buvanendran, A., De Andres, J., Deer, T., Rauck, R., & Huntoon, M. A. (2017) · Regional Anesthesia and Pain Medicine · doi:10.1097/aap.0000000000000700 · Cited by 164
Coupland, C. A. C., Dhiman, P., Barton, G., Morriss, R. K., Arthur, A. J., Sach, T., & Hippisley‐Cox, J. (2011) · Health Technology Assessment · doi:10.3310/hta15280 · Cited by 163
Metadata
- Authors
- Valuck, R. J., Orton, H. D., & Libby, A. M.
- Affiliations
- University of Colorado Anschutz (US)
- Corresponding author
- Valuck, Robert J.
- ORCID
- Libby, Anne M.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2009-08-15
- Volume
- 70
- Issue
- 8
- Pages
- 1069-1077
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2077315601
- Cited by
- 106
- References
- 9
- Citations by year
- 2026: 22 · 2025: 4 · 2024: 5 · 2023: 4 · 2022: 6 · 2021: 9 · 2020: 3 · 2019: 9 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 4 · 2014: 8 · 2013: 9 · 2012: 3
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- antidepressant discontinuation, suicide attempts, depression, antidepressant initiation, antidepressant safety, depression severity, managed care claims data
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Antidepressive Agents, Child, Child, Preschool, Major Depressive Disorder, Dose-Response Relationship, Drug, Drug Administration Schedule, Humans, Longitudinal Studies, Middle Aged, Retrospective Studies, Risk Factors, Severity of Illness Index, Substance Withdrawal Syndrome, Suicide, Attempted, United States, Cohort Studies, Confounding Factors, Epidemiologic, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressant Discontinuation and Risk of Suicide Attempt: A Retrospective, Nested Case-Control Study. https://app.cochat.ai/papers/10.4088/jcp.08m04943
- The paper
- Valuck, R. J., Orton, H. D., & Libby, A. M. (2009). Antidepressant Discontinuation and Risk of Suicide Attempt: A Retrospective, Nested Case-Control Study. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.08m04943
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.